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Hidden hospital mortality in patients with sepsis 
discharged from the intensive care unit
ORIGINAL ARTICLE
INTRODUCTION
Sepsis is a potentially fatal condition associated with organ dysfunction that 
is caused by a dysregulated host response triggered by an infection.(1) It is a 
major cause of hospitalization in the intensive care unit (ICU) and is associated 
with increased morbidity and mortality.(2)
In Portugal, due to the small number of available ICU beds,(3) infection and 
sepsis, which are more readily recognized in severe patients, is highly prevalent, 
and sepsis patients have a higher mortality rate.(2)
It is well known that a significant fraction of patients discharged from the 
ICU to the ward die in the hospital. In a recent meta-analysis of 58 studies 
that included more than 2 million patients, 3 to 7% of the ICU patients 
discharged to the ward died before leaving the hospital.(4) Some of these patients 
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Objective: To evaluate the impact 
of the presence of sepsis on in-hospital 
mortality after intensive care unit 
discharge.
Methods: Retrospective, observational, 
single-center study. All consecutive patients 
discharged alive from the intensive care 
unit of Hospital Vila Franca de Xira 
(Portugal) from January 1 to December 
31, 2015 (N = 473) were included and 
followed until death or hospital discharge. 
In-hospital mortality after intensive care 
unit discharge was calculated for septic 
and non-septic patients.
Results: A total of 61 patients 
(12.9%) died in the hospital after being 
discharged alive from the intensive 
care unit. This rate was higher among 
the patients with sepsis on admission, 
21.4%, whereas the in-hospital, post-
intensive care unit mortality rate for 
the remaining patients was nearly half 
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that, 9.3% (p < 0.001). Other patient 
characteristics associated with mortality 
were advanced age (p = 0.02), male sex 
(p < 0.001), lower body mass index (p = 
0.02), end-stage renal disease (p = 0.04) 
and high Simplified Acute Physiology 
Score II (SAPS II) at intensive care unit 
admission (p < 0.001), the presence 
of shock (p < 0.001) and medical 
admission (p < 0.001). We developed a 
logistic regression model and identified 
the independent predictors of in-
hospital mortality after intensive care 
unit discharge.
Conclusion: Admission to the 
intensive care unit with a sepsis 
diagnosis is associated with an increased 
risk of dying in the hospital, not only 
in the intensive care unit but also after 
resolution of the acute process and 
discharge from the intensive care unit.
DOI: 10.5935/0103-507X.20190037
This is an open access article under the CC BY license https://creativecommons.org/licenses/by/4.0/).
Hidden hospital mortality in patients with sepsis discharged from the intensive care unit 123
Rev Bras Ter Intensiva. 2019;31(2):122-128
had limitations of care due to the severity of their clinical 
condition, whether it was acute or chronic.(5) However, a 
large number died unexpectedly, which seems to be related 
to both comorbidities and the acute clinical insult.(2,6)
The decision to discharge a patient to the ward is often 
based on clinical criteria, namely, “stabilization”, which is 
often poorly validated. The use of such criteria may be 
especially important in populations at risk of dying in 
the ward after ICU discharge. With a careful approach 
to the data presented by some epidemiological studies,(2,6) 
it is possible to observe a significant excess of mortality 
in the ward among patients admitted to the ICU with 
sepsis. This excess may be related to premature discharge 
and suboptimal therapeutic approaches and care on the 
ward.(7,8) Identifying these high-risk populations should 
be of paramount importance to improve the process of 
care,(9) namely by creating objective criteria for discharge 
or for the use of progressive transition.(10)
In this study, we evaluated the mortality and hospital 
length of stay of patients discharged from the ICU 
without an indication for limitation of care. We measured 
the impact of the presence of sepsis on admission to the 
ICU on in-hospital mortality (i.e., mortality that occurred 
after being discharged alive from the ICU). We also 
evaluated potential risk factors for in-hospital, post-ICU 
mortality, focusing on those that were identifiable during 
hospitalization in the ICU.
METHODS
We performed a single-center, retrospective, 
observational study to assess in-hospital mortality after 
ICU discharge. The Hospital Vila Franca de Xira Research 
and Ethics Committee approved the design of the study. 
Informed consent was waived due to the observational 
and retrospective nature of the study.
All consecutive patients discharged alive from the ICU 
of Hospital Vila Franca de Xira (Portugal) for one year, 
from January 1 to December 31, 2015, were included. 
Patients for whom there was a decision to limit of care 
or to preclude readmission to the ICU (N = 18) were 
excluded from further analysis.
Hospital Vila Franca de Xira is a small hospital near 
Lisbon (260 beds). As expected, the ICU receives mainly 
medical and surgical patients (roughly 75% - 25%), with 
a very low rate of trauma patients. The mean Simplified 
Acute Physiology Score (SAPS) II score of patients is 
usually high (46.4 in 2015). The ICU has 8 level III 
beds. An intermediate care unit with 12 beds is associated 
with the same department and has common nursing and 
medical staff.
In this study, we collected demographic data, 
including sex, age, type of admission (either surgical or 
medical) and location (emergency room, operating room, 
ward). Laboratory data on admission (lactate) and clinical 
information (the presence of shock, comorbidities, such 
as hypertension, diabetes mellitus, chronic renal disease, 
heart failure and active neoplasia) were recorded. Disease 
severity on admission to the ICU was assessed by the 
calculation of the SAPS II. Sepsis was defined as the 
presence of infection (suspected or microbiologically 
documented) associated with systemic manifestations, 
including organ failure,(1) which led to the provision 
of antibiotic therapy, according to the physician in 
charge. The infection was categorized as acquired in the 
community or in the hospital, according to commonly 
used criteria.(1) When a patient experienced more than 
one infectious episode, each was recorded and accounted 
for. Each patient was included only once (first episode of 
hospitalization in the ICU).
All data were recorded in a file specially created for this 
study.
Statistical analysis
Continuous variables are expressed as the mean ± 
standard deviation according to their distribution; discrete 
variables are expressed as the total number (percentage).
Univariate analysis was performed using the chi-
square test (for discrete variables) or Student’s T or 
Mann-Whitney tests (for continuous variables) according 
to the data distribution. The variables that were identified 
in the univariate analysis as potentially associated with 
in-hospital mortality after ICU discharge (considering 
a p < 0.1) were included in a logistic regression model. 
All these variables were assessed 2 to 2 for the exclusion 
of significant correlations. A coefficient r < 0.3 was 
considered sufficient to exclude this correlation. In cases 
where a correlation was found, the variable considered 
to be of the greatest clinical importance was included in 
the model. For the logistic regression model, the results 
are expressed as odds ratios (OR) with 95% confidence 
intervals (95%CI).
As the SAPS II score is predictive of in-ward mortality, 
and we believe that the inclusion of this score can 
compensate for possible imbalances that may exist in 
patients’ admission characteristics. In fact, the SAPS II 
score accounts for age, type of admission (either surgical 
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or medical), presence of significant comorbidities and 
clinical severity on admission to the ICU.
All statistical tests were two-tailed, and a value of p 
< 0.05 was considered statistically significant. Statistical 
analysis was performed using the Statistical Package for 
Social Science (SPSS) version21 (SAS Institute, Cary, 
NC) software package.
RESULTS
During the study period, 473 patients were discharged 
alive from the ICU without a decision to limit care or 
to preclude ICU readmission. All of these patients were 
retrospectively screened for the presence of infection and 
sepsis at ICU admission (N = 140, 29.6%).
The clinical characteristics of patients with or without 
infection upon admission to the ICU are presented in 
table 1.
Infected patients more often had a severe disease on 
admission (significantly higher SAPS II and the presence 
of shock). Intensive care unit-acquired infections were 
also more frequent in these patients (15% versus 4.8%, 
p = 0.001). In contrast, comorbidities were more 
commonly reported in noninfected patients (Table 1).
After discharge from the ICU, 61 (12.9%) patients 
died in the hospital, usually on the ward. As expected, the 
SAPS II was lower in patients who were discharged alive 
from the hospital (37.1 ± 15.7 versus 51.5 ± 16.4, p < 
0.001) (Table 2).
The patients who died were significantly older (71.2 
± 15.5 versus 66.2 ± 14.6; p =  0.02), more frequently 
(68.9%) were male (p < 0.001), more often were admitted 
to the ICU for a medical reason (88.5%) and had non 
-clinically relevant higher median lactate levels on 
admission (2.5 [1.4 - 4.5] versus 1.7 [1.2 - 2.6]; p = 0.09). 
Again, the presence of sepsis at admission to the ICU 
was associated with the risk of dying in the hospital, after 
Table 1 - Clinical characteristics at admission of patients discharged alive from 
the intensive care unit, according to the presence of infection
No sepsis
(N = 333)
Sepsis
(N = 140)
p value
Age 67.3 ± 14.3 65.9 ± 16 0.35*
Male sex 193 (58) 72 (51.4) 0.22†
BMI 28.7 ± 6.7 27.3 ± 5.7 0.03*
Type of admission
Medical 240 (72.1) 109 (77.9)
Elective surgery 36 (10.8) 3 (2.1)
Urgent surgery 41 (12.3) 28 (20)
Trauma 16 (4.8) 0 (0) < 0.001†
Comorbidities
Diabetes mellitus 115 (34.6) 42 (30) 0.34†
Active cancer 45 (13.5) 16 (11.4) 0.65†
End-stage renal disease 13 (3.9) 8 (5.7) 0.46†
Chronic heart failure 93 (27.9) 28 (20) 0.08†
Arterial hypertension 199 (59.8) 75 (53.6) 0.22
Severity of disease
Shock 48 (14.4) 42 (30) < 0.001†
ICU-acquired infection 16 (4.8) 21 (15) 0.001†
SAPS II score 37.4 ± 16.1 42.5 ± 17 0.03*
Lactate 1.7 [1.2 - 2.8] 1.9 [1.4 - 2.9] 0.17‡
Glasgow Coma Score 13.5 ± 2.7 13.6 ± 2.5 0.67*
Length of ICU stay 3 [2 - 4] 3 [2 - 7] < 0.001‡
In-hospital mortality 31 (9.3) 30 (21.4) < 0.001‡
Readmission to the ICU 17 (5.1) 8 (5.7) 0.79
BMI - body mass index; ICU - intensive care unit; SAPS - Simplified Acute Physiology Score. 
* Student’s t test; † Chi square test; ‡ Mann-Whitney U test. Data are presented as N (%), 
mean ± standard deviation or median [interquartile range], according to data distribution.
Table 2 - Univariate analysis of factors associated with mortality after intensive 
care unit discharge
Survivors
(N = 412)
Nonsurvivors
(N = 61)
p value
Age 66.2 ± 14.6 71.2 ± 15.5 0.02*
Male sex 223 (54.1) 42 (68.9) < 0.001†
BMI 28.5 ± 6.5 26.4 ± 6.3 0.02*
Type of admission
Medical 295 (71.6) 54 (88.5)
Elective surgery 38 (9.2) 1 (1.6)
Urgent surgery 64 (15.5) 5 (8.2)
Trauma 15 (3.6) 1 (1.6) < 0.001†
Sepsis on admission 110 (26.7) 30 (49.2) 0.001†
ICU-acquired infection 28 (6.8) 9 (14.8) 0.04†
Comorbidities
Diabetes mellitus 139 (33.8) 18 (29.5) 0.56†
Active cancer 56 (13.6) 5 (8.2) 0.31†
End-stage renal disease 15 (3.6) 6 (9.8) 0.04†
Chronic heart failure 107 (26) 14 (23) 0.75†
Arterial hypertension 244 (59.2) 30 (49.2) 0.17†
Severity of disease
Shock 62 (15) 28 (45.9) < 0.001†
SAPS II score 37.1 ± 15.7 51.5 ± 16.4 < 0.001*
Lactate 1.7 [1.2 - 2.6] 2.5 [1.4 - 4.5] 0.09‡
Glasgow Coma Score 13.5 ± 2.7 13.6 ± 2.5 0.67*
BMI - body mass index; ICU - intensive care unit; SAPS - Simplified Acute Physiology Score. 
* Student’ T test; † Chi square test; ‡ Kruskal-Wallis test. Data presented as N (%), mean ± 
standard deviation or median [interquartile range], according to data distribution.
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Table 3 - Focus of infection of the septic patients and outcomes
N Mortality Age SAPS II Male sex
Abdominal 33 7 (21.2) 69.6 ± 14.2 45.6 ± 15.7 12 (36.4)
Bacteremia 8 3 (37.5) 72.9 ± 4.7 38.8 ± 13.0 5 (62.5)
Respiratory 57 15 (26.3) 66.2 ± 17.5 44.2 ± 17.6 33 (57.9)
Skin and soft tissues 6 1 (16.7) 69.0 ± 18.6 37.5 ± 14.8 4 (66.7)
Urinary 20 2 (10) 63.4 ± 13.6 41.8 ± 19.0 5 (25)
CNS 5 0 (0) 56.0 ± 15.4 26.2 ± 20.8 2 (40)
Other 11 2 (18.2) 55.5 ± 18.1 38.5 ± 14.0 11 (100)
SAPS - Simplified Acute Physiology Score; CNS - central nervous system. Data presented as N (%) or mean ± standard deviation.
ICU discharge (21.1% versus 10.7%, p = 0.001), but not 
with ICU readmission (Table 1). In our cohort, patients 
discharged after an episode of bacteremia had a higher 
mortality risk (Table 3). Having had a respiratory or 
abdominal focus of infection was also associated with an 
increased risk of dying on the ward.
Interestingly, of the other studied comorbidities, 
namely, active cancer, HIV infection, chronic heart 
failure, arterial hypertension or diabetes mellitus, none 
were associated with in-hospital mortality after discharge 
from the ICU (Table 2).
Accordingly, we developed a logistic regression model 
to evaluate the independent associations with the risk of 
dying in the hospital, after ICU discharge. We found that 
the presence of sepsis on admission to the ICU (OR 2.32, 
95%CI 1.28 - 4.24), male sex (OR 2.26, 95%CI 1.21 - 
4.24) and the SAPS II score (OR per point 1.05, 95%CI 
1.03 - 1.07) were independent predictors of in-hospital 
death (Table 4).
Table 4 - Independent predictors of in-hospital mortality after intensive care unit 
discharge
OR 95%CI p value
Male sex 2.26 1.21 - 4.24 0.012
SAPS II (per point) 1.05 1.03 - 1.07 < 0.001
Sepsis on admission 2.32 1.28 - 4.24 0.006
OR - odds ratio; 95%CI - confidence interval; SAPS - Simplified Acute Physiology Score. 
Also included in the model: age, lactate, diagnosis of end-stage renal disease, intensive 
care unit-acquired infection, body mass index, and type of admission. Shock was excluded 
because of collinearity with the SAPS II.
This association of sepsis with mortality in the ICU 
is well known(6) and may persist even after hospital 
discharge,(11) eventually becoming associated with a 
high incidence or worsening of a previously existent 
cardiovascular disease.(12) Although the relationship of 
cardiovascular disease risk with sepsis decreases with time, 
it may persist for several years.(12)
In this study, we focused only on mortality in the 
hospital after ICU discharge. We believe that this risk 
factor, sepsis on admission to the ICU, should be taken 
into account when allocating resources, namely, in the 
admission of patients to functional units with greater 
availability of human resources, the use of progressive step-
down or hand-over programs or even the prolongation 
of hospitalization in the ICU, to help reduce morbidity 
and mortality. Our data suggests that such measures are 
especially important for patients admitted with bacteremia 
or an abdominal or respiratory infection.
Some patients die soon after discharge from the ICU, 
and most of these deaths are associated with a plan to limit 
care and are to be expected. In our study, we identified 
and excluded 18 patients in this situation. However, 
other patients die unexpectedly on the ward, and these 
death could potentially be avoided with a better process 
of care.(13)
Several patients are discharged from the ICU to an 
intermediate care unit to receive a higher standard of 
care than can be provided on the ward. Nevertheless, a 
study of 690 patients discharged from the ICU failed to 
demonstrate an association between ICU discharge to an 
intermediate care unit and a better outcome.(14) Of note, 
another multicenter study showed a survival benefit for 
the overall population when intermediate care units were 
available in the hospital (adjusted OR 0.63, 95%CI 0.45 
to 0.88), although this benefit was not necessarily related 
to admission to those units.(15)
DISCUSSION
In this study, we report an association between sepsis on 
admission to the ICU and hospital mortality that persists 
after resolution of the acute disease and discharge from the 
ICU (OR 2.32, 95%CI 1.28 - 4.24) and is independent 
of comorbidities or age.
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We clearly need to better understand the prognostic 
factors associated with this late mortality risk to identify 
patients who may benefit from this resource. In a British 
study, Daly et al.(16) suggested that prolonging the 
hospitalization of critically ill patients with sepsis in the ICU 
for an additional 48 hours could reduce hospital mortality 
by approximately 39%. In addition, even the hour and 
weekday of discharge may influence the outcome of these 
patients,(17) probably in relation to the varying availability of 
resources in the hospital. Discharge to an intermediate care 
unit often occurs at late hours,(18) which may jeopardize the 
potential benefits of a progressive step-down approach.
Lactate has also been proposed as a possible prognostic 
factor for patients admitted to the ICU,(19) especially the 
septic population.(20) However, there are multiple pitfalls 
in the interpretation of either absolute or relative lactate 
levels,(21) and their relationship with outcomes may not 
be straightforward, as we found in our study. Another 
potential prognostic factor is the C-reactive protein 
concentration at ICU discharge, which may help to 
identify patients at risk.(22,23)
The in-hospital mortality rate of patients discharged 
from the ICU in our study was high, 12.9%; this was in 
sharp contrast with a meta-analysis published in 2014, 
where the mean hospital mortality after ICU discharge 
was only 6.8%.(4) However, these numbers are common 
in Portuguese ICUs.(2,22) We believe that these higher 
values were mostly related to the case mix, namely, the 
high prevalence of comorbidities in the Portuguese ICU 
population,(2) the predominance of patients admitted for 
medical reasons or sepsis and even the high prevalence of 
patients admitted from the ward.
On the other hand, a higher late mortality on the 
ward among patients admitted to the ICU with sepsis was 
evident in other studies, although it was rarely mentioned. 
In the International Study of Prevalence and Outcomes 
of Infection in Intensive Care Units (EPIC) II,(6) the 
in-hospital mortality after ICU discharge was 7.3%. This 
mortality rate was clearly higher in those patients who 
were deemed to be infected on the study day: 10.3% in 
infected patients versus 4.6% in others (estimated OR 2.4, 
p < 0.001).(6) In the Portuguese multicenter study Infection 
on Admission to the Intensive Care (INFAUCI), the in-
hospital mortality after ICU discharge was 11.5%, but it 
was higher (14.2%) in patients who had an infection on 
admission (9.6% in the others, OR 1.6, p < 0.001).(2) In 
another cohort of surgical patients, the mortality risk in 
the first year after hospital discharge was also increased 
in the septic population (OR 1.71, 95%CI 1.46 - 2.00), 
particularly among the elderly (> 75 years) and those with 
the highest Charlson scores.(24)
In fact, this persistent mortality risk among the septic 
population may be related to the continuation of the 
inflammatory state that persists even after the clinical 
resolution of sepsis, a risk that was unveiled in patients 
addmited with community-acquired pneumonia.(25) In 
a multicenter study, GenIMS, (25) high levels of IL-6 at 
hospital discharge were associated with a higher 3-month 
mortality that may be related to a high prevalence of new 
or worsening cardiovascular disease, which may persist for 
several years.(12,26)
Consequently, we believe that a more aggressive 
approach to care for these patients, not only in the short 
term but also in the long term, may lead to a reduction in 
mortality and morbidity.
Our study has several limitations: it was a retrospective, 
single-center study. Sepsis was identified by the physician in 
charge (at ICU discharge), and the risk of misclassification 
was real. Moreover, our exclusion of patients with a 
limitation of care were based only on the decision made 
at ICU discharge and did not consider eventual additional 
decisions made later, on the ward.
We adjusted the mortality risk to the SAPS II score. 
However, these scores is determined at ICU admission and do 
not include some important predictors of mortality at ICU 
discharge, such as the level of consciousness, the presence of 
tracheostomy, the need for noninvasive ventilation, ICU-
acquired muscular weakness, and ulcerations.
However, our study focused specifically on the in-
hospital period after ICU discharge (usually “blind” 
in epidemiological studies), excluded patients with a 
plan to limit care (who naturally have higher mortality 
rates and contaminate the interpretation of the results), 
included consecutive patients throughout a whole year 
(thus eliminating seasonal variations that may exist) and 
evaluated data for different comorbidities. Furthermore, 
the identified mortality was relatively high, which allowed 
the impact of different risk factors to be discriminated.
CONCLUSION
In conclusion, we found an association between being 
admitted to the intensive care unit with an infectious 
disease and sepsis and an increased risk of dying in the 
hospital, even after discharge from the intensive care unit 
after the acute process was resolved. This association was 
independent of age or comorbidities.
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Objetivo: Avaliar o impacto da presença de sepse na morta-
lidade hospitalar após alta da unidade de terapia intensiva.
Métodos: Ensaio retrospectivo, observacional, em centro 
único. Todos os pacientes que consecutivamente receberam alta 
vivos da unidade de terapia intensiva do Hospital Vila Franca de 
Xira (Portugal) entre 1º de janeiro e 31 de dezembro de 2015 (N 
= 473) foram incluídos e acompanhados até o óbito ou alta do 
hospital. A mortalidade hospitalar após alta da unidade de tera-
pia intensiva foi calculada para pacientes sépticos e não sépticos.
Resultados: Um total de 61 pacientes (12,9%) faleceu no 
hospital após receber alta vivos da unidade de terapia intensiva. 
Esta taxa foi mais elevada entre os pacientes que tinham sepse 
quando da admissão (21,4%), enquanto a taxa de mortalida-
de hospitalar após alta da unidade de terapia intensiva para os 
demais pacientes foi aproximadamente a metade (9,3%), com 
p < 0,001. Outras características dos pacientes associadas com 
mortalidade foram idade avançada (p = 0,02), sexo masculino 
(p < 0,001), índice mais baixo de massa corporal (p = 0,02), 
nefropatia terminal (p = 0,04) e, quando da admissão à uni-
dade de terapia intensiva, escore elevado segundo o Simplified 
Acute Physiology Score (SAPS II); p < 0,001, presença de choque 
(p < 0,001) e admissão por causas clínicas (p < 0,001). Desen-
volvemos um modelo de regressão logística e identificamos os 
preditores independentes de mortalidade hospitalar após alta da 
unidade de terapia intensiva.
Conclusão: A admissão à unidade de terapia intensiva com 
diagnóstico de sepse se associa com maior risco de morrer no 
hospital, não apenas na unidade de terapia intensiva quanto 
também após a resolução do processo agudo e alta da unidade 
de terapia intensiva.
RESUMO
Descritores: Sepse; Mortalidade hospitalar; Unidades de 
terapia intensiva
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